Results 191 to 200 of about 322,328 (395)

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

open access: yesNew England Journal of Medicine, 2012
P. Tricoci   +41 more
semanticscholar   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia   +2 more
wiley   +1 more source

Thrombin regulates components of the fibrinolytic system in human mesangial cells

open access: bronze, 1990
Luis M. Villamediana   +7 more
openalex   +1 more source

The nature of thrombin and anti‐thrombin

open access: yesThe Journal of Physiology, 1913
B J, Collingwood, M T, Macmahon
openaire   +3 more sources

Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients

open access: diamond, 2020
А. Б. Сумароков   +4 more
openalex   +2 more sources

Molecular characteristics of polysulfated fractions from the green seaweed <i>Caulerpa cupressoides</i> and actions on thrombin generation <i>in vitro [PDF]

open access: diamond, 2019
José Ariévilo Gurgel Rodrigues   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy